Displaying 271 - 280 of 628
Image
Acute Myeloid Leukemia (AML)
Updated:
AML is one of four main types of leukemia. It progresses quickly if untreated. It features cancerous blood cells, often called “blasts.” AML typically affects adults over the age of 65 and is slightly more common in men.
Leukemia
Peripheral T-cell Lymphoma
Updated:
Learn more about peripheral T-cell lymphoma and the resources we have available.
Image
Angioimmunoblastic T-cell Lymphoma (AITL)
Updated:
AITL is a rare, fast-growing (aggressive) T-cell subtype of non-Hodgkin lymphoma (NHL) and a common subtype of peripheral T-cell lymphoma (PTCL). AITL typically affects adults over 50.
Lymphoma
Blood cancer ambassador featured in Canadian Blood Services video
Updated:
Adam, of Toronto, is a blood and stem cell recipient who was diagnosed with leukemia two days after finding out he was going to become a father.
The role of pharmacists in supporting access to novel cancer treatments
Updated:
The Leukemia & Lymphoma Society of Canada were honoured to be invited to speak at the Canadian Association of Pharmacy in Oncology (CAPhO) in Moncton, New Brunswick this month.
Canadians are ‘dying to be a priority’ in accessing cancer treatments: Open letter to the Premiers
Updated:
LLSC is at the frontlines in advocating for more timely, equitable cancer treatment access, and this week this issue was elevated publicly in light of a meeting of Canada’s premiers (a group called Council of Federation).
Line Up for Change in access to cancer care
Updated:
Christina Sit of The Leukemia & Lymphoma Society of Canada, and a co-chair of Cancer Action Now alliance, speaks with CityNews Toronto reporter about why she and other patient advocacy groups and cancer survivors are at Queen's Park on Nov 18, 2024 to "Line up for…
Introducing Our Retail Partner, Lumberjacq
Updated:
Jacquie Rowe is a reclaimed wood artist living in Ontario, currently living with blood cancer. The LLSC has helped Jacquie throughout her diagnosis, and is proud to partner with her business, Lumberjacq, as a retail partner.
$3 million for blood cancer research through partnership with CRS
Updated:
The Cancer Research Society (CRS) and the Leukemia and Lymphoma Society of Canada (LLSC) are jointly announcing an exceptional partnership, amounting to $3 million, dedicated to research on blood cancers.
Persons newly diagnosed with a blood cancer need reliable resources
Updated:
Blood cancer survivors Gary Su, Kolter Bouchard, and Holly Ewanyshyn, talk about their experience learning more from The Leukemia & Lymphoma Society of Canada.